Home| About us| Widget| login/register| For authors| For reviewers |Submit a paper
(close)

(Ctrl-click to select multiple journals)


How should we address you?

Your email address


 Yes, sign up now
 Sign up for general news too

Privacy Statement
 
 
 

Clinical Medicine: Therapeutics

Synopsis: An open access, peer reviewed electronic journal that covers therapeutics in human clinical medicine.


Indexing: 2 major databases.  Pubmed indexing for NIH-funded research.

Processing time: Decision in 2 weeks for 90% of papers.

Visibility: Accessible to all internet users.

 

RSS

NEWS

TWITTER
View factor
for journal
40044


About this journal

ISSN: 1179-1713



Aims and scope:

Clinical Medicine: Therapeutics focuses on the role of therapeutics in human clinical medicine.

Editorial standards and procedures:

Submissions, excluding editorials, letters to the editor and dedications, will be peer reviewed by two reviewers.  Reviewers are required to provide fair, balanced and constructive reports.  

Under our Fairness in Peer Review Policy authors may appeal against reviewers' recommendations which are ill-founded, unobjective or unfair.  Appeals are considered by the Editor in Chief or Associate Editor.

Papers are not sent to peer reviewers following submission of a revised manuscript. Editorial decisions on re-submitted papers are based on the author's response to the initial peer review report.

Indexing:

This journal is indexed by:

  • DOAJ 
  • OAIster

National Institutes of Health Public Access Policy compliant:

As of April 7 2008, the US NIH Public Access Policy requires that all peer reviewed articles resulting from research carried out with NIH funding be deposited in the Pubmed Central archive.

If you are an NIH employee or grantee Libertas Academica will ensure that you comply with the policy by depositing your paper at Pubmed Central on your behalf. 



 
 
 


Management of Asthma with ICS and LABAs: different treatment strategies

Authors: M van den Berge, NHT ten Hacken, HAM Kerstjens and DS Postma
Publication Date: 03 Apr 2009
Clinical Medicine: Therapeutics 2009:1 77-93

M van den Berge, NHT ten Hacken, HAM Kerstjens and DS Postma

Department of Pulmonology, University Medical Center Groningen, Groningen, The Netherlands.

Abstract  

In recent years considerable insight has been gained in the optimal management of adult asthma. In asthma patients who have persistent symptoms despite the daily use of (a low dose) inhaled corticosteroids (ICS), adding a long- acting β2-agonist to ICS improves asthma control and decreases the number of exacerbations. Currently two different LABAs are available, ie formoterol and salmeterol. The most important difference between both LABAs is a more rapid onset of action of formoterol (2–5 minutes) when compared to salmeterol (15–30 minutes). Partly based on these pharmacological differences, two major different approaches have been put forward to asthma management. The first approach (Gaining Optimal Asthma Control) is promoted by the producers of fl uticasone/salmeterol and recommends to step up ICS to the dose needed to achieve optimal asthma control in order to keep the patient symptom free and to prevent exacerbations. The second approach is promoted by the producers of budesonide/formoterol and recommends a low maintenance dose which can be adjusted up or down according to the clinical control of asthma. Initially, a treatment strategy with Adjustable Maintenance Dosing with budesonide/formoterol was introduced. At a later time, this concept was changed to the Symbicort Maintenance And Reliever Therapy (SMART) approach. The aim of this manuscript is to review the current literature on the management of asthma with ICS and LABAs and to discuss the different treatment strategies.



Post comment




No comments yet...Be the first to comment.

Bookmark this article

LINKEDIN FACEBOOK

Add to Mixx! MIXX YAHOO! BUZZ

PERMALINK DIGG


Sign up for free journal updates

How should we address you?
Your email address
 Yes, sign up now


Recently published in this journal

Safety and Efficacy of Eplerenone in the Management of Essential Hypertension
- 25/Aug/2009

Antipsychotic Drug Treatment for Patients with Schizophrenia: Theoretical Background, Clinical Considerations and Patient Preferences
- 17/Aug/2009

Benefits of ACE Inhibitors in Diabetes
- 14/Aug/2009

Insomnia: A Review of the Use of Eszopiclone
- 12/Aug/2009

Management of EGFR-Mutant Non-Small Cell Lung Cancer: Focus on Gefitinib
- 12/Aug/2009

Clopidogrel Bisulfate: A Review of its Use in the Management of Acute Coronary Syndrome
- 07/Aug/2009

A Review of Enteric-coated Mycophenolate Sodium  for Renal Transplant Immunosuppression
- 07/Aug/2009

Pharmacotherapy of Epilepsy: Focus on Levetiracetam
- 05/Aug/2009

Current and Prospective Pharmacotherapies in Gastroesophageal Reflux Disease
- 05/Aug/2009

Pharmacotherapy of Candida Infections with Echinocandins
- 04/Aug/2009

Management Options in Chronic Stable Angina Pectoris: Focus on Ranolazine
- 31/Jul/2009

Pharmacotherapy with Pamidronate Disodium of Osteolytic Bone Metastases of Breast Cancer, Osteolytic Lesions of Multiple Myeloma, and Paget’s Disease
- 30/Jul/2009

Pharmacotherapy of Hematologic Malignancies with Tipifarnib
- 29/Jul/2009

Zolmitriptan and the Triptan Era
- 22/Jul/2009

Pharmacotherapy of Complicated Urinary Tract and Intra-abdominal Infections with Doripenem
- 15/Jul/2009

Glimepiride-pioglitazone Hydrochloride in the Treatment  of Type 2 Diabetes
- 15/Jul/2009

Safety and Efficacy of the bi-Sulfydryl ACE-Inhibitor Zofenopril in the Management of Cardiovascular Disease
- 15/Jul/2009

Pregabalin and Fibromyalgia Syndrome: A Treatment Option
- 15/Jul/2009

Bevacizumab: Its Place in the Treatment of Advanced  Non-small Cell Lung Cancer
- 13/Jul/2009

Safety and Efficacy of Lamotrigine in Older Adults with Epilepsy and Co-Morbid Depressive Symptoms
- 09/Jul/2009

Management of Transfusional Chronic Iron Overload: Focus on Deferasirox
- 09/Jul/2009

Experience with Cinacalcet for Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease Stage III and IV
- 09/Jul/2009

Tipranavir: A Review of its Use in Therapy of HIV Infection
- 09/Jul/2009

Single Sevikar®: Combination Therapy for the Treatment of Hypertension
- 01/Jul/2009

Safety and Efficacy of I(131) Tositumomab in the Treatment of non-Hodgkin’s Lymphoma
- 01/Jul/2009

Triptans in the Treatment of Migraine
- 01/Jul/2009

Treatment Options in Smoking Cessation: What Place  for Bupropion Sustained-Release?
- 30/Jun/2009

Tetrabenazine in Huntington’s Disease Chorea
- 29/Jun/2009

Pharmacokinetics of Lopinavir in the LPV/R-Meltrex Formulation Compared to the LPV/R-Soft Gelatine Capsule in HIV Infected Patients
- 29/Jun/2009

Pharmacotherapy Update: Hyoscine Butylbromide in the Treatment of Abdominal Spasms
- 23/Jun/2009

Pharmacotherapy Update: Quetiapine use in Bipolar Disorder - What does the evidence tell us?
- 19/Jun/2009

Emerging Therapies for the Treatment of Essential Tremor
- 17/Jun/2009

Safety and Efficacy of Panitumumab in the Treatment of Metastatic Colorectal Cancer
- 12/Jun/2009

Lapatinib in the Treatment of Breast Cancer
- 12/Jun/2009

Secondary Stroke Prevention, and the Role of Antiplatelet Therapies
- 11/Jun/2009

First-line Treatment of Metastatic Breast Cancer: Focus  on Bevacizumab
- 10/Jun/2009

A Review of Trastuzumab-Based Therapy in Patients  with HER2-positive Metastatic Breast Cancer
- 08/Jun/2009

Hormone Refractory Prostate Cancer: Focus on Sipuleucel-T
- 08/Jun/2009

Pharmacotherapy of Excessive Sleepiness: Focus on Armodafinil
- 28/May/2009

Safety and Efficacy of Ambrisentan in the Treatment of Pulmonary Arterial Hypertension
- 27/May/2009

Therapeutic Options in Multiple Myeloma: Focus on Bortezomib
- 26/May/2009

A Review of Nelarabine in the Treatment of T-cell Lymphoblastic Leukemia/Lymphoma
- 21/May/2009

A Review of Levofloxacin for the Treatment of Bacterial Infections
- 15/May/2009

Pharmacotherapy of HIV: Focus on Etravirine
- 15/May/2009

The Prevention of Respiratory Syncytial Virus Infection in Children: Focus on Palivizumab
- 14/May/2009

Safety and Efficacy Review of Doxycycline
- 14/May/2009

Pharmacotherapy Update: Fludarabine in the Treatment of Non-Hodgkin’s Lymphoma
- 11/May/2009

A Review of the Pharmacokinetics, Pharmacodynamics and Efficacy of Zolmitriptan in the Acute Abortive Treatment of Migraine
- 11/May/2009

Metastatic Bone Disease in Patients with Solid Tumors—Burden of Bone Disease and the Role of Zoledronic Acid
- 08/May/2009

Lanreotide Autogel® in the Treatment of Acromegaly
- 07/May/2009

Sorafenib in Hepatocellular Carcinoma
- 06/May/2009

Hypertension Management and End Organ Protection: Focus on Aliskiren
- 01/May/2009

Pharmacotherapy of Oral Mucositis with Palifermin
- 01/May/2009

The Rise and Fall of Rosiglitazone
- 30/Apr/2009

Pharmacotherapy of Systemic Sclerosis: focus on Bosentan
- 16/Apr/2009

Efficacy and safety of fixed-dose Lercanidipine-Enalapril for the treatment of hypertension
- 20/Apr/2009

Current Approaches to the Treatment of Gastrointestinal Infections: Focus on Nitazoxanide
- 20/Apr/2009

A Review of Pramlintide in the Management of Diabetes
- 19/Apr/2009

Safety and Efficacy of Pioglitazone/Metformin Combination Therapy in Treatment of Type 2 Diabetes: A Rationale for Earlier Use
- 17/Apr/2009

Pharmacotherapy Options in Atrial Fibrillation: Focus on Vernakalant
- 17/Apr/2009

Pharmacotherapy of Retinal Diseases with Ranibizumab
- 16/Apr/2009

Sitaxentan for the Oral Treatment of Pulmonary Arterial Hypertension: Benefits from Endothelin Receptor Subtype Selectivity?
- 16/Apr/2009

Pharmacotherapy of HIV: A Focus on Atazanavir/Ritonavir a Potent and Convenient Once Daily Ritonavir Boosted Protease-Inhibitor for HIV-1 Infected Adults
- 09/Apr/2009

Hypertension: Focus on Olmesartan Medoxomil
- 08/Apr/2009

Pharmacotherapy of Paget’s Disease of Bone: Focus on Zoledronic Acid
- 08/Apr/2009

A Review of Delayed-Release MMX Mesalamine: It’s Use in the Treatment of Ulcerative Colitis
- 07/Apr/2009

Raltegravir: Its use in the Treatment of HIV Infection
- 03/Apr/2009

Efficacy and Safety of Sitagliptin in the Treatment of Type 2 Diabetes
- 03/Apr/2009

Management of Asthma with ICS and LABAs: different treatment strategies
- 03/Apr/2009

Pharmacotherapy of Insomnia: Focus on Zolpidem Extended Release
- 01/Apr/2009

Safety and efficacy update: alvimopan in postoperative ileus
- 01/Apr/2009

Pharmacotherapy of Chronic Hepatitis B with Entecavir
- 31/Mar/2009

Temsirolimus: a review of its use in the treatment of advanced renal cell carcinoma
- 31/Mar/2009

Anastrozole Use in Early Stage Breast Cancer of Post-Menopausal Women
- 31/Mar/2009

A review of the use of telbivudine in the treatment of chronic hepatitis B
- 30/Mar/2009

Management of Multiple Myeloma and Myelodysplastic Syndrome: Focus on Lenalidomide
- 30/Mar/2009

Cevimeline for the treatment of dry mouth in patients with Sjogren’s syndrome
- 20/Mar/2009

The Treatment of Ankylosing Spondylitis and Psoriatic Arthritis with Etanercept: A Comprehensive Review
- 09/Mar/2009

Pharmacotherapy of Bipolar I Disorder: Focus on Aripiprazole
- 04/Mar/2009



Related journals...